C60-Curcumin Nasal Spray for Polyp Regression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatment options for respiratory conditions such as asthma and nasal polyps are limited and often invasive, with no cure available for asthma and potential irreversible damage to healthy tissues from surgery.
Innovation Solution
A nasal spray or inhalable composition combining fullerene (C60), curcumin, and medium chain triglycerides like black seed oil, which allows curcumin to cross the blood-brain barrier when administered, treating respiratory and brain disorders through inhalation or oral consumption.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If invasive surgery is used to treat nasal polyps, then polyp removal is achieved, but healthy tissues are damaged irreversibly
Solution Approach 1:
The patent uses C60-curcumin-lipid complex as an intermediary substance that delivers curcumin specifically to nasal polyps through nasal administration. This mediator enables targeted therapy that removes polyps while protecting healthy surrounding tissues from the harmful effects of aggressive treatments like surgery.
Solution Approach 2:
The patent changes the physical and chemical parameters of curcumin by forming a C60-curcumin-lipid complex, which enhances curcumin's bioavailability, stability, and targeted delivery capabilities. This parameter transformation allows curcumin to effectively treat nasal polyps at lower concentrations without the tissue damage associated with surgical intervention.
2Reliability
If steroids are used to manage asthma symptoms, then symptom control is achieved, but no cure is available
Solution Approach 1:
The C60-curcumin-lipid complex acts as a delivery system that transports curcumin directly to inflamed airways, enhancing its anti-inflammatory effects. This targeted delivery mechanism transforms curcumin from a mere symptom manager into a potential disease-modifying treatment that addresses the underlying inflammation causing asthma.
Solution Approach 2:
The patent creates a composite material system consisting of C60 fullerene, curcumin, and lipid components. This composite structure combines the antioxidant and anti-inflammatory properties of curcumin with the delivery capabilities of C60 and lipid, producing a synergistic effect that goes beyond simple symptom management.
3Reliability
If conventional treatments are used for respiratory conditions, then current symptoms are addressed, but new treatment options are limited
Solution Approach 1:
The patent develops a novel composite nanomedicine system combining C60 fullerene, curcumin, and lipid components. This composite material represents a new class of respiratory treatments that differs fundamentally from conventional steroids and bronchodilators, offering expanded therapeutic options for respiratory conditions.
Solution Approach 2:
The patent fundamentally changes the pharmacokinetic parameters of curcumin through C60 complexation and lipid formulation, transforming it from a poorly bioavailable compound into an effective respiratory treatment. This parameter transformation creates a new treatment modality that can be administered via inhalation or nasal routes, expanding therapeutic versatility.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Demonstrated significant reduction in asthma symptoms and nasal polyp regression in human volunteers, offering a non-invasive treatment option for various respiratory and brain disorders.
Implementation Method 1
The contemplated nutraceutical compositions contain, as primary ingredients, a fullerene, curcumin, and a medium chain triglyceride... buckminsterfullerene C60 is used as the fullerene
Data Source
AI summary
A nutraceutical composition comprising fullerene (e.g., C60), curcumin, and a medium chain triglyceride. Preferably, blackseed oil is used to provide medium chain triglyceride. The nutraceutical composition can be packaged in a mist-producing device and used as a nasal spray or an inhaler. Preferably, the nasal spray is substantially free of particles having a size greater than 0.2 μm. The nutraceutical composition can be used to treat respiratory conditions (e.g., asthma, nasal polyps, etc.) or brain disorders through nasal spray, inhaling, or oral administration.